Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ephedrine
2. Ephedrine Erythro Isomer
3. Ephedrine Renaudin
4. Ephedrine Sulfate
5. Erythro Isomer Of Ephedrine
6. Hydrochloride, Ephedrine
7. Renaudin, Ephedrine
8. Sal Phedrine
9. Sal-phedrine
10. Salphedrine
11. Sulfate, Ephedrine
1. 50-98-6
2. (-)-ephedrine Hydrochloride
3. L-ephedrine Hydrochloride
4. 1-ephedrine Hydrochloride
5. Ephedrine Hcl
6. Ephedrine (hydrochloride)
7. Nlj6390p1z
8. Nsc-759611
9. Ephedronguent
10. (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol Hydrochloride
11. Altusin
12. Dsstox_cid_25825
13. Dsstox_rid_81156
14. Dsstox_gsid_45825
15. Ephedrinium Chloride
16. L-ephedrine, Hydrochloride
17. (-)-ephedrin Hydrochloride
18. Cas-50-98-6
19. Einecs 200-074-6
20. (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride
21. Unii-nlj6390p1z
22. Ephedrine Hydrochloride [usan:ban:jan]
23. Ncgc00094665-01
24. Rezipres
25. (1r,2s)-(-)-ephedrine Hydrochloride
26. Ephedrini Hydrochloridum
27. N-methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid [german]
28. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, Hydrochloride, (r-(r*,s*))-
29. Ec 200-074-6
30. Schembl22822
31. Ephedrine Hydrochloride (tn)
32. Ephedrine Hydrochloride Racemic
33. N-methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid
34. Chembl2146102
35. Dtxsid1045825
36. Chebi:31541
37. Hy-b1195a
38. Str01942
39. Ephedrine Hydrochloride [mi]
40. Tox21_111310
41. Ephedrine Hydrochloride (jp17/usp)
42. Ephedrine Hydrochloride [jan]
43. Akos015895154
44. Tox21_111310_1
45. Ccg-229523
46. Cs-4803
47. Ephedrine Hydrochloride [mart.]
48. Ephedrine Hydrochloride [vandf]
49. Nsc 759611
50. Benzenemethanol, .alpha.-[(1s)-1-(methylamino)ethyl]-, Hydrochloride, (.alpha.r)-
51. Benzenemethanol, Alpha-((1s)-1-(methylamino)ethyl)-, Hydrochloride, (alphar)-
52. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, Hydrochloride, (theta-(theta,s))-
53. Ephedrine Hydrochloride [usp-rs]
54. Ephedrine Hydrochloride [who-dd]
55. Ephedrine Hydrochloride [who-ip]
56. Ncgc00015408-03
57. (1r,2s)-(-)-ephedrinehydrochloride
58. Ephedrine Hydrochloride [ep Impurity]
59. Ephedrine Hydrochloride [orange Book]
60. (-)-ephedrine Hydrochloride [who-ip]
61. (1r,2s)-(-)-ephedrine Hydrochloride, 99%
62. Ephedrine Hydrochloride [ep Monograph]
63. D01386
64. Ephedrine Hydrochloride [usp Monograph]
65. Ephedrini Hydrochloridum [who-ip Latin]
66. 066e127
67. Q27284939
68. (1r,2s)-ephedrine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
69. Ephedrine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
70. (r-(r*,s*))-.alpha.-(1-(methylamino)ethyl)benzenemethanol Hydrochloride [who-ip]
71. Benzenemethanol, .alpha.-(1-(methylamino)ethyl)-, Hydrochloride, (r-(r*,s*))-
72. Benzenemethanol, Alpha-((1s)-1-(methylamino)ethyl)-, Hydrochloride (1:1), (alphar)-
73. Ephedrine Hydrochloride, Drug Precursor, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 201.69 g/mol |
|---|---|
| Molecular Formula | C10H16ClNO |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 201.0920418 g/mol |
| Monoisotopic Mass | 201.0920418 g/mol |
| Topological Polar Surface Area | 32.3 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 121 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adrenergic Agents
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Central Nervous System Stimulants
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16619
Submission : 2003-06-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17817
Submission : 2004-11-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9278
Submission : 1991-08-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7857
Submission : 1988-09-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15753
Submission : 2001-12-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4783
Submission : 1982-11-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12230
Submission : 1996-11-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18271
Submission : 2005-03-31
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12017
Submission : 1996-06-27
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6193
Submission : 1986-02-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : R1-CEP 2002-193 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2010-06-17
Type : Chemical
Substance Number : 487
Certificate Number : R1-CEP 2006-234 - Rev 01
Status : Valid
Issue Date : 2015-12-15
Type : Chemical
Substance Number : 487
Certificate Number : R1-CEP 2002-157 - Rev 00
Status : Valid
Issue Date : 2009-06-30
Type : Chemical
Substance Number : 487
Certificate Number : R0-CEP 2004-152 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2005-12-15
Type : Chemical
Substance Number : 487
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
About the Company : Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine an...
Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.
About the Company : Pharm-Rx has earned an outstanding reputation since its establishment in 1991, serving as a reputable importer and distributor of active ingredients to the pharmaceutical, nutritio...
About the Company : At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biot...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - 23.5MG/5ML (4...DOSAGE - SOLUTION;INTRAVENOUS - 23.5MG/5ML (4.7MG/ML)
USFDA APPLICATION NUMBER - 213536
DOSAGE - SOLUTION;INTRAVENOUS - 47MG/10ML (4....DOSAGE - SOLUTION;INTRAVENOUS - 47MG/10ML (4.7MG/ML)
USFDA APPLICATION NUMBER - 213536
DOSAGE - SOLUTION;INTRAVENOUS - 47MG/ML (47MG...DOSAGE - SOLUTION;INTRAVENOUS - 47MG/ML (47MG/ML)
USFDA APPLICATION NUMBER - 213536
DOSAGE - SOLUTION;INTRAVENOUS - 47MG/5ML (9.4...DOSAGE - SOLUTION;INTRAVENOUS - 47MG/5ML (9.4MG/ML)
USFDA APPLICATION NUMBER - 213536
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : HiCel acts as a strong dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel CE15 offers a superior mouthfeel with less chalkiness and gritness in chewable tablets and orally disintegrating tablets (ODTs).
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Guar Gum Excipient
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel HFE has superior compactibility, low sensitivity to lubrication & better disintegration properties. It is used in direct compression of ODTs.
Dosage Form : Tablet
Grade : Oral
Brand Name : HiCel MCC Spheres
Application : Co-Processed Excipients
Excipient Details : HiCel MCC Spheres are extremely versatile which are used for controlled release or sustained release formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel MCG is use in oral suspensions as a stabilizer. It is a good binder for tablets & excellent thickener as well.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Carboxymethyl cellulose sodium
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel SMCC has unique combination which result in optimum compaction & superior flow properties.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : HiCellac is used in direct compression & dry granulation suitable for low dose formulations where API content uniformity is critical.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : Hilose is used in oral pharmaceutical formulations as a super disintegrant for capsules and tablets formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Stargel is used in oral pharmaceuticals as a disintegrant in tablet and capsules formulations. It is also used as a suspending agent & stabilizer.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Sodium Starch Glycolate
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Direct Compression
Granulation
Thickeners and Stabilizers
Lubricants & Glidants
Co-Processed Excipients
Solubilizers
Taste Masking
Coating Systems & Additives
Film Formers & Plasticizers
Controlled & Modified Release
Chewable & Orodispersible Aids
Topical
Emulsifying Agents
Parenteral
API Stability Enhancers
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of Ephedrine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ephedrine Hydrochloride manufacturer or Ephedrine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ephedrine Hydrochloride manufacturer or Ephedrine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ephedrine Hydrochloride API Price utilized in the formulation of products. Ephedrine Hydrochloride API Price is not always fixed or binding as the Ephedrine Hydrochloride Price is obtained through a variety of data sources. The Ephedrine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid, including repackagers and relabelers. The FDA regulates N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid supplier is an individual or a company that provides N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid active pharmaceutical ingredient (API) or N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid finished formulations upon request. The N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers may include N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid API manufacturers, exporters, distributors and traders.
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid DMF (Drug Master File) is a document detailing the whole manufacturing process of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid active pharmaceutical ingredient (API) in detail. Different forms of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid DMFs exist exist since differing nations have different regulations, such as N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid DMF submitted to regulatory agencies in the US is known as a USDMF. N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid USDMF includes data on N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid Drug Master File in Japan (N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid JDMF) empowers N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid JDMF during the approval evaluation for pharmaceutical products. At the time of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid Drug Master File in Korea (N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid. The MFDS reviews the N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid KDMF as part of the drug registration process and uses the information provided in the N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid KDMF to evaluate the safety and efficacy of the drug.
After submitting a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers with KDMF on PharmaCompass.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEP of the European Pharmacopoeia monograph is often referred to as a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid Certificate of Suitability (COS). The purpose of a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid to their clients by showing that a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEP has been issued for it. The manufacturer submits a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEP (COS) as part of the market authorization procedure, and it takes on the role of a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEP holder for the record. Additionally, the data presented in the N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid DMF.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers with CEP (COS) on PharmaCompass.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid written confirmation (N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid WC) is an official document issued by a regulatory agency to a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid manufacturer, verifying that the manufacturing facility of a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid APIs or N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid finished pharmaceutical products to another nation, regulatory agencies frequently require a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid WC (written confirmation) as part of the regulatory process.
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid suppliers with NDC on PharmaCompass.
N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid GMP manufacturer or N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid GMP API supplier for your needs.
A N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CoA (Certificate of Analysis) is a formal document that attests to N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid's compliance with N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid specifications and serves as a tool for batch-level quality control.
N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CoA mostly includes findings from lab analyses of a specific batch. For each N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid EP), N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid USP).
